DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Schulze-Koops H, Krueger K, Vallbracht I. et al.
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab.
Annals of the Rheumatic Diseases 2020;
DOI: 10.1136/annrheumdis-2020-218075.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.